drugset / Trial / NCT02378649

PDEI Following Mitral Valve Surgery in Patients With Pulmonary Hypertension

NCT02378649

RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized, placebo controlled, single center clinical trial for evaluation of efficacy and safety of Sildenafil administration in the cardiac ICU following Mitral Valve (MV) Surgery in patients with pre-operative Significant Pulmonary Hypertension.

Timeline

Start
2015-03
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 40 mg Other